Clinical Edge Journal Scan

Clinical Edge Journal Scan

Comparative efficacy and safety of Gla-300 and Deg-100 in T2D

Publish date: August 31, 2022

• Read More

Clinical Edge Journal Scan

T2D: No evidence to suggest increased fracture risk with DPP-4i, GLP-1 RA, and SGLT-2i

Publish date: August 31, 2022

• Read More

Clinical Edge Journal Scan

DPP-4 inhibitor but not GLP-1 RA raises risk for acute liver injury in T2D

Publish date: August 31, 2022

• Read More

Clinical Edge Journal Scan

Exenatide as a new treatment option for youth with T2D

Publish date: August 31, 2022

• Read More

Clinical Edge Journal Scan

Commentary: Diabetes Drug Comparisons, August 2022

Publish date: August 2, 2022

• Read More

Clinical Edge Journal Scan

Serum 25-hydroxyvitamin D levels inversely correlated with albuminuria in patients with diabetes

Publish date: July 31, 2022

• Read More

Clinical Edge Journal Scan

Sarcopenia index significantly linked to subclinical atherosclerosis prevalence in T2D

Publish date: July 31, 2022

• Read More

Clinical Edge Journal Scan

Real-world insights of initiating or switching to insulin degludec/aspart in T2D

Publish date: July 31, 2022

• Read More

Clinical Edge Journal Scan

SGLT2i vs DPP4i lowers death risk in T2D

Publish date: July 31, 2022

• Read More

Clinical Edge Journal Scan

Prusogliptin add-on to metformin safe and effective in T2D

Publish date: July 31, 2022

• Read More

Pages

• « first
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• last »